– USA, MA – Algorics Inc., one of the fastest-growing biometrics and data science companies, adds Amit Patel to its board of directors.
“We are glad to have Amit on board and believe his industry insights will be key as we enter the next phase of growth at Algorics,” said CEO, Nithiya Ananthakrishnan. “With our diverse client base across large biopharma, emerging biotechs, CROs, and medical devices companies, Amit’s expertise will help us drive increasing value for our customers.”
About Amit M. Patel
Amit M Patel comes with twenty-five years of healthcare industry experience with publicly traded, private-equity-backed, and start-up companies in various capacities including C-suite, board member, advisor, and investor. Amit has expertise across biopharma, pharma services, and other healthcare segments, and is currently a board member at multiple private-equity-backed portfolio companies.
“I welcome the opportunity to be involved with Algorics as a board member during this high-growth phase of the company, and supporting its mission of accelerating data-centric drug development,” said Amit Patel.
In his prior executive roles with Azurity Pharmaceuticals, Capsugel, and Dr. Reddy’s Laboratories, Amit Patel has led businesses with over $1B in gross revenue and 1000 employees, and a global presence across the Americas, Europe, and Asia.
About Algorics
Founded in 2013, Algorics is a specialized data sciences partner to the life sciences industry focusing on data management, biostatistics, programming, and data standardization. The company supports a global portfolio of biopharmaceutical and CRO clients with cost-effective and high-quality analytical services underpinned by technology know-how and access to high-quality talent across US, Europe, and Asia. We help our customers increase productivity and accelerate development with our technology-backed solutions to enable data standardization and faster statistical reporting.
For more information: https://algorics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.